全关节置换术研究中如何测量成本效益?文献系统综述
该系统综述检索2005至2020年文献,纳入38项评估全髋关节置换术(THA)和全膝关节置换术(TKA)成本效益的经济学分析,多数采用Markov模型(68%)、社会视角(45%)或卫生系统视角(39%),82%的研究使用质量调整生命年(QALYs)作为主要质量指标且均显示QALYs显著改善,THA/TKA相较非手术治疗具有强成本效益,未延迟的手术比延迟干预更具成本效益。
要点
- THA/TKA相较非手术治疗具有强成本效益。
- 未延迟的THA/TKA比延迟干预更具成本效益。
- 82%研究以QALYs为主要质量指标,均显示QALYs显著改善。
核心结论
- 鉴于关节置换术的高经济影响,需要持续评估成本效益。
- 本系统综述纳入研究中24%发表于15年研究期的最后4年,凸显持续汇总数据的必要性。
- 未来研究应结合外科医生提供者工作价值来纳入THA和TKA的成本效益,以支持卫生政策和报销。
研究设计与样本
- 系统综述,检索2005年至2020年文献。
- 检索数据库包括OVID Medline、PubMed、成本效益分析注册库、Google Scholar、Elton B. Stephens Co。
- 共纳入38项评估THA/TKA成本效益的经济学分析。
- 研究设计主要为Markov模型(68%)、队列研究(16%)和随机试验(8%)。
- 多数研究采用社会视角(45%)或卫生系统视角(39%)。
主要发现
- THA/TKA相较非手术治疗具有强成本效益。
- 未延迟的THA/TKA手术比延迟干预更具成本效益。
- 82%的研究使用QALYs作为主要质量指标,所有这些研究中QALYs获得均显著改善。
- 纳入研究中24%发表于15年研究期的最后4年。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As volumes of total hip arthroplasty (THA) and total knee arthroplasty (TKA) continue to rise, it is important to understand their economic impact. No systematic review on cost-effectiveness of THA/TKA has been performed since 2016 despite recent changes in the healthcare environment. The purpose of the study is to provide a contemporary analysis of the cost-effectiveness of total joint arthroplasty and the use of quality-adjusted life years (QALYs). METHODS: A systematic review was performed from 2005 to 2020. Online databases (OVID Medline, PubMed, Cost-Effectiveness Analysis Registry, Google Scholar, Elton B. Stephens Co) were queried to identify economic analyses that evaluated the cost-effectiveness of THA/TKA. RESULTS: In total, 38 studies met the screening criteria. Study designs were primarily Markov models (68%), cohort studies (16%), and randomized trials (8%). Most studies adopted either a societal perspective (45%) or a health system perspective (39%). Analysis revealed that THA/TKA was strongly cost-effective compared to nonsurgical treatment. THA/TKA procedures that were not delayed were more cost-effective than delayed intervention. The majority of studies used QALYs as the primary quality metric (82%); in all these studies there was a significant improvement in QALYs gained. CONCLUSION: Given the high economic impact of arthroplasty, ongoing assessment of cost-effectiveness is needed. Twenty-four percent of studies included in this systematic review were published in the last 4 years of this 15-year study period, highlighting the need for continuous assessment of aggregate data. Future studies should incorporate the cost-effectiveness of THA and TKA with respect to the work-value provided by surgeon providers to support health policy and reimbursement.
引用
- Lan RH, Yu J, Samuel LT, et al. How Are We Measuring Cost-Effectiveness in Total Joint Arthroplasty Studies? Systematic Review of the Literature. J Arthroplasty. 2020. PMID: 32680755. doi:10.1016/j.arth.2020.06.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。